SIM
PVLA

Spark Investment Management’s Palvella Therapeutics PVLA Stock Holding History

Spark Investment Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,044
Closed -$302K – 551
2019
Q4 		$302K Sell
1,044
-406
-28% -$113K 0.04% 399
2019
Q3 		$395K Hold
1,450
– – 0.05% 268
2019
Q2 		$545K Sell
1,450
-2,206
-60% -$658K 0.04% 362
2019
Q1 		$979K Sell
3,656
-848
-19% -$201K 0.05% 339
2018
Q4 		$958K Buy
4,504
+2,782
+162% +$863K 0.07% 325
2018
Q3 		$771K Sell
1,722
-599
-26% -$260K 0.04% 416
2018
Q2 		$941K Buy
+2,321
New +$1.1M 0.06% 379
2016
Q1 		– Sell
-378
Closed -$69K – 847
2015
Q4 		$69K Buy
+378
New +$63.5K 0.01% 688

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Spark Investment Management's PVLA Position: Q1 2020 in Review

Spark Investment Management sold out of Palvella Therapeutics (PVLA) in Q1 2020, closing a stake of 1,044 shares — an estimated $302K sold.

Spark Investment Management first reported a position in PVLA in Q4 2015 and held it in 8 quarters. The position peaked at $979K in Q1 2019. 95 funds tracked by Wall St. Rank hold PVLA as of Q1 2020.

  • Spark Investment Management reported no remaining Palvella Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 1,044 Palvella Therapeutics shares in Q1 2020, an estimated $302K.
  • Spark Investment Management first reported a position in Palvella Therapeutics in Q4 2015 and held it in 8 quarters.
  • Spark Investment Management's Palvella Therapeutics position peaked at $979K in Q1 2019.
  • 95 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.